On this episode of Stock Movers:
- Novo Nordisk pared its forecast for a fourth time this year on lagging sales of its blockbuster drugs Wegovy and Ozempic, underscoring the urgency facing its new CEO.
- Orsted has confirmed its full-year profit guidance, seeking to reassure investors of its financial stability after a weak third quarter..
- M&S expects profit in the second half to rebound to at least last year’s level as the British retailer tries to move on from a costly cyberattack.

On this episode of Stock Movers: - Novo Nordisk pared its forecast for a fourth time this year on lagging sales of its blockbuster drugs Wegovy and Ozempic, underscoring the urgency facing its new CEO. - Orsted has confirmed its full-year profit guidance, seeking to reassure investors of its financial stability after a weak third quarter.. - M&amp;S expects profit in the second half to rebound to at least last year&rsquo;s level as the British retailer tries to move on from a costly cyberattack.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Novo Up, Orsted Gains, M&S Dips

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b0cfcc59-740d-4771-9a86-b38c00aaf6da/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers, we preview some of the stock's we're watching in the week ahead: 

Microsoft (MSFT), Alphabet (GOOGL) & Meta (META) all will announce earnings for the first quarter on Wednesday. Bloomberg Intelligence Global Tech Research Head Mandeep Singh previews each of them with host Nathan Hager. 

Today's biggest winners and losers in the stock market. On this episode of Stock Movers, we preview some of the stock's we're watching in the week ahead: Microsoft (MSFT), Alphabet (GOOGL) &amp; Meta (META) all will announce earnings for the first quarter on Wednesday. Bloomberg Intelligence Global Tech Research Head Mandeep Singh previews each of them with host Nathan Hager.&nbsp;

Week Ahead: Microsoft, Alphabet & Meta Headline Big Tech Earnings

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/38417705-fcc2-47ba-ad6c-b436016e9d28/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners of the week: 

- Intel (INTC) shares hit a record high after the chipmaker delivered a sales forecast that shattered Wall Street expectations, showing that it’s finally benefiting from a boom in AI spending. Intel’s stock soared in New York trading Friday, reaching a record high for the first time since August 2000. The single-day percentage gain was the largest since October 1987, and it brought Intel’s year-to-date increase to 124%.

- Lululemon (LULU) fell the most in more than seven months after naming a Nike veteran as chief executive officer, underscoring investor skepticism that the yogawear brand can recapture the growth of past years. The shares dropped as much as 12% on Thursday in in New York trading, the most since September 2025. The stock had fallen more than 21% this year as of Wednesday’s close.

- Psychedelic-linked stocks, like Compass Pathways (CMPS) surged this week after President Donald Trump signed an executive order last weekend to expedite research and access. On Monday, US-traded shares of Compass Pathways Plc spiked as much as 53% while AtaiBeckley Inc. surged by 37%. GH Research PLC jumped 34% and Definium Therapeutics, Inc. rallied 16%. The AdvisorShares Psychedelics ETF (PSIL) also climbed as much as 20% — touching its highest intraday level since July 2023.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners of the week: - Intel (INTC) shares hit a record high after the chipmaker delivered a sales forecast that shattered Wall Street expectations, showing that it&rsquo;s finally benefiting from a boom in AI spending. Intel&rsquo;s stock soared in New York trading Friday, reaching a record high for the first time since August 2000. The single-day percentage gain was the largest since October 1987, and it brought Intel&rsquo;s year-to-date increase to 124%. - Lululemon (LULU) fell the most in more than seven months after naming a Nike veteran as chief executive officer, underscoring investor skepticism that the yogawear brand can recapture the growth of past years. The shares dropped as much as 12% on Thursday in in New York trading, the most since September 2025. The stock had fallen more than 21% this year as of Wednesday&rsquo;s close. - Psychedelic-linked stocks, like Compass Pathways (CMPS) surged this week after President Donald Trump signed an executive order last weekend to expedite research and access. On Monday, US-traded shares of Compass Pathways Plc spiked as much as 53% while AtaiBeckley Inc. surged by 37%. GH Research PLC jumped 34% and Definium Therapeutics, Inc. rallied 16%. The AdvisorShares Psychedelics ETF (PSIL) also climbed as much as 20% &mdash; touching its highest intraday level since July 2023.

Weekly Roundup: Intel's Big Rally, Lululemon Falls Sharply, Psychedelic-Tied Stocks Soar

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/86879ecb-f733-4c70-a321-b436016a387c/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers: 

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.

- Intel (INTC) shares hit a record high after the chipmaker delivered a sales forecast that shattered Wall Street expectations, showing that it’s finally benefiting from a boom in AI spending. The upbeat outlook suggests that Chief Executive Officer Lip-Bu Tan is making progress on a once-improbable turnaround. After lining up major investments in Intel last year — helping to strengthen the company’s balance sheet — he’s now delivering on a promise to improve operations. Intel’s stock soared as much as 28% to $85.22 in New York trading Friday, reaching a record high for the first time since August 2000. It had gained 81% this year heading into the report.

- Alphabet (GOOGL) will invest $10 billion in Anthropic PBC, with another $30 billion potentially to follow, strengthening the relationship between two companies that are at once partners and rivals in the race to build artificial intelligence. Anthropic said that Google is committing to invest $10 billion now in cash at a $350 billion valuation, the same amount it was valued at in a funding round in February, not including the recent money raised. The Alphabet Inc.-owned company will invest another $30 billion if Anthropic hits performance targets, the startup said Friday, and support a significant expansion of Anthropic’s computing capacity. Shares of Google were up on Friday after the news.

- HCA Healthcare (HCA) tumbled Friday after it opted against raising its yearly profit and sales guidance even though first quarter profit beat analysts’ views, meaning it could foresee challenges later in the year. The hospital operator reaffirmed its yearly adjusted earnings forecast of $29.10 to $31.50 a share. It reported first-quarter adjusted earnings of $7.15 a share, compared to the average analyst estimate of $7.10 a share. Adjusted earnings before interest, taxes, depreciation and amortization missed estimates.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec. - Intel (INTC) shares hit a record high after the chipmaker delivered a sales forecast that shattered Wall Street expectations, showing that it&rsquo;s finally benefiting from a boom in AI spending. The upbeat outlook suggests that Chief Executive Officer Lip-Bu Tan is making progress on a once-improbable turnaround. After lining up major investments in Intel last year &mdash; helping to strengthen the company&rsquo;s balance sheet &mdash; he&rsquo;s now delivering on a promise to improve operations. Intel&rsquo;s stock soared as much as 28% to $85.22 in New York trading Friday, reaching a record high for the first time since August 2000. It had gained 81% this year heading into the report. - Alphabet (GOOGL) will invest $10 billion in Anthropic PBC, with another $30 billion potentially to follow, strengthening the relationship between two companies that are at once partners and rivals in the race to build artificial intelligence. Anthropic said that Google is committing to invest $10 billion now in cash at a $350 billion valuation, the same amount it was valued at in a funding round in February, not including the recent money raised. The Alphabet Inc.-owned company will invest another $30 billion if Anthropic hits performance targets, the startup said Friday, and support a significant expansion of Anthropic&rsquo;s computing capacity. Shares of Google were up on Friday after the news. - HCA Healthcare (HCA) tumbled Friday after it opted against raising its yearly profit and sales guidance even though first quarter profit beat analysts&rsquo; views, meaning it could foresee challenges later in the year. The hospital operator reaffirmed its yearly adjusted earnings forecast of $29.10 to $31.50 a share. It reported first-quarter adjusted earnings of $7.15 a share, compared to the average analyst estimate of $7.10 a share. Adjusted earnings before interest, taxes, depreciation and amortization missed estimates.

Closing Bell: Intel Eclipse Dot-Com High, Alphabet Rises, HCA Healthcare Tumbles 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a47fe147-9ad2-4aff-b129-b43601587d23/transcript

Novo Up, Orsted Gains, M&S Dips

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips